StonvexLoading…
StonvexStonvexStonvexCore line items from AIV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $400.00K | $7.60M | $5.50M | $3.50M |
Operating Income | $2.03M | $-15.85M | $52.66M | $58.85M |
Net Income | $-7.74M | $547.16M | $249.90M | $-33.22M |
EPS (Diluted) | $-0.05 | $3.87 | $1.80 | $-0.24 |
Total Assets | Not available | $1.68B | $2.08B | $1.87B |
Total Liabilities | Not available | $1.12B | $1.82B | $1.59B |
Cash & Equivalents | $320.36M | $394.89M | $404.38M | $41.38M |
Free Cash Flow OCF − CapEx | $-46.88M | $-91.53M | $-51.45M | $-32.12M |
Shares Outstanding | 140.45M | 140.16M | 140.16M | 137.38M |